inhaled therapy

ANTWERP, Belgium — September 14, 2026 Agomab Therapeutics NV announced positive Phase 1 results for AGMB-447, an investigational inhaled,...

BOSTON — September 8, 2026 Avalyn Pharma presented new data at the European Respiratory Society (ERS) International Congress 2026...

Crystal Lake, Illinois — September 7, 2026 Aptar Pharma announced a collaboration with Aceso Therapeutics to advance development activities...

Zhuhai, China — September 7, 2026 Rezubio announced the successful first cohort dosing of RZ-520 in a Phase 1...

SAN FRANCISCO, Calif., July 27, 2026 Revagenix, Inc. announced that the first participant has been dosed in the Phase...

Find Jobs Across Pharma, Biotech & Life Sciences

Discover verified job opportunities from top companies worldwide. Apply easily and grow your career in the life sciences industry.

BOSTON, MA, July 20, 2026 Kinaset Therapeutics announced that the first patient has been dosed in the Phase 2b...

HONG KONG, July 8, 2026 Sino Biopharmaceutical Limited has announced that its subsidiary, Chia Tai Tianqing Pharmaceutical Group Co.,...

TURIN, Italy | June 19, 2026 Kither Biotech has announced the successful completion of its first-in-human Phase 1 clinical...